理化学研究所ライフサイエンス技術基盤研究センター RIKEN Center for Life Science Technologies

トピックス一覧

  • 研究成果

    CLSTから発表された最新の研究成果をご紹介します。
  • おしらせ

    受賞や協定の締結など、CLSTからのお知らせを掲載します。
  • イベント

    セミナーやシンポジウムなど、各種イベントをご紹介します。

一般の方へ

一人でも多くの方にCLSTの研究を知っていただくために、4つのコンテンツを集めました。
「読む」では研究者のインタビューや講演録などの記事を、「視聴する」では動画をご覧いただけます。「会いに行く」では、実際に研究者と会って話せるイベントをご案内します。「勉強する」は、研究内容をもっと深く知りたい方向けのコンテンツです。
  • 読む
  • 会いに行く
  • 視聴する
  • 勉強する

制御分子設計研究チーム _論文リスト一覧

制御分子設計研究チーム

1

Molecular basis for the reverse reaction of African human trypanosomes glycerol kinase.

Balogun EO, Inaoka DK, Shiba T, Kido Y, Tsuge C, Nara T, Aoki T, Honma T, Tanaka A, Inoue M, Matsuoka S, Michels PA, Kita K, Harada S.
Mol Microbiol, 94(6), 1315-1329 (2014).
2

Crystal structures of the S6K1 kinase domain in complexes with inhibitors.

Niwa H, Mikuni J, Sasaki S, Tomabechi Y, Honda K, Ikeda M, Ohsawa N, Wakiyama M, Handa N, Shirouzu M, Honma T, Tanaka A, Yokoyama S.
J Struct Funct Genomics, 15(3), 153-164 (2014).
3

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

Okada-Iwabu M, Yamauchi T, Iwabu M, Honma T, Hamagami K, Matsuda K, Yamaguchi M, Tanabe H, Kimura-Someya T, Shirouzu M, Ogata H, Tokuyama K, Ueki K, Nagano T, Tanaka A, Yokoyama S, Kadowaki T.
Nature, 503(7477), 493-499 (2013).
4

Biochemical characterization of highly active Trypanosoma brucei gambiense glycerol kinase, a promising drug target.

Balogun EO, Inaoka DK, Shiba T, Kido Y, Nara T, Aoki T, Honma T, Tanaka A, Inoue M, Matsuoka S, Michels PAM, Harada S, Kita K.
J Biochem, 154(1), 77-84 (2013).
5

A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo

Saito Y, Yuki H, Kuratani M, Hashizume Y, Takagi S, Honma T, Tanaka A, Shirouzu M, Mikuni J, Handa N, Ogahara I, Sone A, Najima Y, Tomabechi Y, Wakiyama M, Uchida N, Tomizawa-Murasawa M, Kaneko A, Tanaka S, Suzuki N, Kajita H, Aoki Y, Ohara O, Shultz LD, Fukami T, Goto T, Taniguchi S, Yokoyama S, Ishikawa F.
Sci Transl Med, 5(181), 181ra52 (2013).
6

Structure of the trypanosome cyanide-insensitive alternative oxidase.

Shiba T, Kido Y, Sakamoto K, Inaoka DK, Tsuge C, Tatsumi R, Takahashi G, Balogun EO, Nara T, Aoki T, Honma T, Tanaka A, Inoue M, Matsuoka S, Saimoto H, Moore AL, Harada S, Kita K.
Proc Natl Acad Sci U S A, 110(12), 4580-4585 (2013).
7

Prediction of ligand-induced structural polymorphism of receptor interaction sites using machine learning.

Takaya D, Sato T, Yuki H, Sasaki S, Tanaka A, Yokoyama S, Honma T.
J Chem Inf Model, 53(3), 704-716 (2013).
8

Crystallization and preliminary X-ray crystallographic analyses of Thermus thermophilus backtracked RNA polymerase.

Murayama Y, Sekine S, Yokoyama S.
Acta Crystallogr Sect F-Struct Biol Cryst Commun, 69(Pt2), 174-177 (2013).
9

Identification of novel drug-resistant EGFR mutant inhibitors by in silico screening using comprehensive assessments of protein structures.

Sato T, Watanabe H, Tsuganezawa K, Yuki H, Mikuni J, Yoshikawa S, Kukimoto-Niino M, Fujimoto T, Terazawa Y, Wakiyama M, Kojima H, Okabe T, Nagano T, Shirouzu M, Yokoyama S, Tanaka A, Honma T.
Bioorg Med Chem, 20(12), 3756-3767 (2012).
11

Blockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2.

Nishikimi A, Uruno T, Duan X, Cao Q, Okamura Y, Saitoh T, Saito N, Sakaoka S, Du Y, Suenaga A, Kukimoto-Niino M, Miyano K, Gotoh K, Okabe T, Sanematsu F, Tanaka Y, Sumimoto H, Honma T, Yokoyama S, Nagano T, Kohda D, Kanai M, Fukui Y.
Chem Biol, 19(4), 288-297 (2012).
12

A novel Pim-1 kinase inhibitor targeting residues that bind the substrate peptide.

Tsuganezawa K, Watanabe H, Parker L, Yuki H, Taruya S, Nakagawa Y, Kamei D, Mori M, Ogawa N, Tomabechi Y, Handa N, Honma T, Yokoyama S, Kojima H, Okabe T, Nagano T, Tanaka A.
J Mol Biol, 417(3), 240-252 (2012).
13

Prediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4.

Yuki H, Honma T, Hata M, Hoshino T.
Bioorg Med Chem, 20(2), 775-783 (2012).
14

A new method for induced fit docking (GENIUS) and its application to virtual screening of novel HCV NS3-4A protease inhibitors.

Takaya D, Yamashita A, Kamijo K, Gomi J, Ito M, Maekawa S, Enomoto N, Sakamoto N, Watanabe Y, Arai R, Umeyama H, Honma T, Matsumoto T, Yokoyama S.
Bioorg Med Chem, 19(22), 6892-6905 (2011).
15

A fluorescence correlation spectroscopy-based assay for fragment screening of slowly inhibiting protein-peptide interaction inhibitors.

Mikuni J, Kato M, Taruya S, Tsuganezawa K, Mori M, Ogawa N, Honma T, Yokoyama S, Kojima H, Okabe T, Nagano T, Tanaka A.
Anal Biochem, 402(1), 26-31 (2010).
16

Crystallization and preliminary crystallographic analysis of cyanide-insensitive alternative oxidase from Trypanosoma brucei brucei.

Kido Y, Shiba T, Inaoka DK, Sakamoto K, Nara T, Aoki T, Honma T, Tanaka A, Inoue M, Matsuoka S, Moore A, Harada S, Kita K.
Acta Crystallogr Sect F-Struct Biol Cryst Commun, 66(pt3), 275-278 (2010).
17

Overproduction, purification, crystallization and preliminary X-ray diffraction analysis of Trypanosoma brucei gambiense glycerol kinase

Balogun Emmanuel Oluwadare; Inaoka Daniel Ken; Kido Yasutoshi; Shiba Tomoo; Nara Takeshi; Aoki Takashi; Honma Teruki; Tanaka Akiko; Inoue Masayuki; Matsuoka Shigeru; Michels Paul A. M, Harada Shigeharu; Kita Kiyoshi.
Acta Crystallogr Sect F-Struct Biol Cryst Commun, 66(Pt3), 304-308 (2010).
18

Combining machine learning and pharmacophore-based interaction fingerprint for in silico screening.

Sato T, Honma T, Yokoyama S.
J Chem Inf Model, 50(1), 170-185 (2010).
19

In silico functional profiling of small molecules and its applications.

Sato T, Matsuo Y, Honma T, Yokoyama S.
J Med Chem, 51(24), 7705-7716 (2008).
20

Predicting human liver microsomal stability with machine learning techniques.

Sakiyama Y, Yuki H, Moriya T, Hattori K, Suzuki M, Shimada K, Honma T.
J Mol Graph Model, 26(6), 907-915 (2008).
22

Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design.

Honma T, Hayashi K, Aoyama T, Hashimoto N, Machida T, Fukasawa K, Iwama T, Ikeura C, Ikuta M, Suzuki-Takahashi I, Iwasawa Y, Hayama T, Nishimura S, Morishima H.
J Med Chem, 44(26), 4615-4627 (2001).
23

A Novel Approach for the Development of Selective Cdk4 Inhibitors:  Library Design Based on Locations of Cdk4 Specific Amino Acid Residues

Honma T, Yoshizumi T, Hashimoto N, Hayashi K, Kawanishi N, Fukasawa K, Takaki T, Ikeura C, Ikuta M, Suzuki-Takahashi I, Hayama T, Nishimura S, Morishima H.
J Med Chem, 44(26), 4628-4640 (2001).
24

Crystallographic Approach to Identification of Cyclin-dependent Kinase 4 (CDK4)-specific Inhibitors by Using CDK4 Mimic CDK2 Protein

Ikuta M, Kamata K, Fukasawa K, Honma T, Machida T, Hirai H, Suzuki-Takahashi I, Hayama T, Nishimura S.
J Biol Chem, 276(29), 27548-27554 (2001).
25

Synthesis and biological activities of NB-506 analogues modified at the glucose group.

Ohkubo M, Nishimura T, Kawamoto H, Nakano M, Honma T, Yoshinari T, Arakawa H, Suda H, Morishima H, Nishimura S.
Bioorg Med Chem Lett, 10(5), 419-422 (2000).
26

Synthesis and biological activities of NB-506 analogues: Effects of the positions of two hydroxyl groups at the indole rings.

Ohkubo M, Nishimura T, Honma T, Nishimura I, Ito S, Yoshinari T, Suda HA, Morishima H, Nishimura S.
Bioorg Med Chem Lett, 9(23), 3307-3312 (1999).
27

Total Synthesis of (+)-Obtusenyne.

Fujiwara K, Awakura D, Tsunashima M, Nakamura A, Honma T, Murai A.
J Org Chem, 64(8), 2616-2617 (1999).
28

Biogenetic intermediates, (3e and 3z,12z)-laurediols and (3e and 3z)-12,13- dihydrolaurediols, isolated from Laurencia nipponica.

Fukuzawa, A.; Honma, T.; Takasugi, Y.; Murai, A.
Phytochemistry, 32(6), 1435-1438 (1999).
29

Structural basis for chemical inhibition of human blood coagulation factor Xa.

Kamata K, Kawamoto H, Honma T, Iwama T, Kim SH.
Proc Natl Acad Sci U S A, 95(12), 6630-6635 (1998).
30

Synthesis of dissymmetric indolocarbazole glycosides using the Mitsunobu reaction at the glycosylation step.

Ohkubo, M.; Nishimura, T.; Jona, H.; Honma, T.; Ito, S.; Morishima, H.
Tetrahedron, 53(17), 5937-5950 (1997).
31

Practical Synthesis of Indolopyrrolocarbazoles

Ohkubo M, Nishimura T, Jona H, Honma T, Morishima H.
Tetrahedron, 52(24), 8099-8112 (1996).
32

Novel synthesis of a dihydroxyethylene isostere of renin inhibitors.

Atsuumi S, Ikeura C, Honma T, Morishima H.
Chem Pharm Bull, 42(10), 2164-2166 (1994).

和文論文

1

機械学習による薬物のヒト肝ミクロゾーム安定性の予測

嵜山陽二郎, 幸瞳, 本間光貴.
CBI学会誌,(2),1-5,2009.

CLSTは、2018年4月1日からの理化学研究所第4期中期計画により、3つのセンターに改組されました。制御分子設計研究チームの最新の情報は、下記よりご覧いただけます。


▶ 生命機能科学研究センター 制御分子設計研究チーム [http://www.bdr.riken.jp/jp/research/labs/honma-t-structure/index.html]